You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PR-Positive Breast Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

TNBC - Triple-Negative Breast Cancer Trial (Alkaline Glucosodiene Molecules)

Not yet recruiting
  • TNBC - Triple-Negative Breast Cancer
  • Alkaline Glucosodiene Molecules
  • (no location specified)
Jul 14, 2023

Breast Cancer Trial in São Paulo (radiation, procedure, other)

Recruiting
  • Breast Cancer
  • Radiotherapy
  • +2 more
  • São Paulo, SP, Brazil
    ICESP
Aug 5, 2022

Breast Cancer, HER2-positive Breast Cancer, ER Positive Breast Cancer Trial (Neratinib, Letrozole (L) or Anastrozole (A),

Not yet recruiting
  • Breast Cancer
  • +3 more
  • (no location specified)
Jan 11, 2022

Breast Cancer, HER2-negative Breast Cancer, ER Positive Breast Cancer Trial in Stanford (Infigratinib, Tamoxifen, Omnipaque 350)

Recruiting
  • Breast Cancer
  • +3 more
  • Stanford, California
    Stanford University
Feb 16, 2022

Breast Cancer, Brain Metastases Trial in Guangzhou (Palbociclib, Trastuzumab, Pyrotinib and Fulvestrant)

Recruiting
  • Breast Cancer
  • Brain Metastases
  • Palbociclib, Trastuzumab, Pyrotinib and Fulvestrant
  • Guangzhou, Guangdong, China
  • +1 more
Apr 24, 2022

HER2-positive Breast Cancer Trial in China (TQB2440 injection + Trastuzumab + Docetaxel, Perjeta + Trastuzumab + Docetaxel)

Active, not recruiting
  • HER2-positive Breast Cancer
  • TQB2440 injection + Trastuzumab + Docetaxel
  • Perjeta + Trastuzumab + Docetaxel
  • Chongqing, Chongqing, China
  • +5 more
Aug 3, 2023

Stage IV (Metastatic) Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer Trial in Boston (NERATINIB,

Not yet recruiting
  • Stage IV (Metastatic) Breast Cancer
  • +5 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Oct 25, 2021

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

Suspended
  • Anatomic Stage I Breast Cancer AJCC v8
  • +23 more
  • Short-Term Fasting
  • Chemotherapy
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Jan 23, 2023

Use of Zoledronic Acid in Breast Cancer Trial in Asyut (Zoledronic Acid 4 MG)

Recruiting
  • Use of Zoledronic Acid in Breast Cancer
  • Zoledronic Acid 4 MG
  • Asyūţ, Asyut, Egypt
    Clinical Oncology Department, Assuit University Hospital
Dec 5, 2021

Breast Cancer Trial in United States (bicalutamide, diagnostic laboratory biomarker analysis, immunohistochemistry staining

Completed
Has Results
  • Breast Cancer
  • San Francisco, California
  • +7 more
Jul 8, 2022

After Neoadjuvant Chemotherapy for Breast Cancer

Recruiting
  • TN ER-/PR-/HER2- Breast Cancer
  • +3 more
  • Standard Trimodality Breast Imaging
  • Minneapolis, Minnesota
    University of Minnesota Masonic Cancer Center
Aug 13, 2021

Metastatic Breast Cancer Trial in Athens

Recruiting
  • Metastatic Breast Cancer
    • Athens, Greece
      Hellenic Society of Medical Oncology
    Feb 9, 2021

    Breast Cancer Trial in Sydney ([68Ga]GA-NeoB)

    Recruiting
    • Breast Cancer
    • Sydney, New South Wales, Australia
      St Vincent's Hospital
    May 22, 2023

    Breast Cancer Female Trial (Pyrotinib and Trastuzumab)

    Not yet recruiting
    • Breast Cancer Female
    • Pyrotinib and Trastuzumab
    • (no location specified)
    Sep 11, 2023

    Advanced Solid Tumor, Advanced Breast Cancer, Metastatic Breast Cancer Trial (BGB-43395, Fulvestrant, Letrozole)

    Not yet recruiting
    • Advanced Solid Tumor
    • +8 more
    • (no location specified)
    Nov 13, 2023

    Breast Cancer, Brain Metastases, Radiotherapy Trial in Shanghai (Combination use of SRT with T-DXd)

    Not yet recruiting
    • Breast Cancer
    • +2 more
    • Combination use of SRT with T-DXd
    • Shanghai, China
      Fudan University Shanghai Cancer Center
    Oct 14, 2023

    Advanced HR-positive and HER2-negative Breast Cancer; CDK4/6 Inhibitor Treatment Failed Trial in Hangzhou (dalpiciclib;

    Recruiting
    • Advanced HR-positive and HER2-negative Breast Cancer; CDK4/6 Inhibitor Treatment Failed
    • dalpiciclib; fluvestrant; compound gossypol acetate tablets
    • Hangzhou, Zhejiang, China
      zhejiangCH
    Nov 9, 2023

    T-Dxd in Treatment of HER2-positive BCBM After Prior Pyrotinib

    Recruiting
    • Breast Cancer
    • Beijing, Beijing, China
    • +1 more
    Nov 13, 2023

    HER2-positive Breast Cancer Trial in Guanzhou (Eribulin mesylate injection?Pertuzumab?Trastuzumab)

    Recruiting
    • HER2-positive Breast Cancer
    • Eribulin mesylate injection、Pertuzumab、Trastuzumab
    • Guanzhou, Guangdong, China
      LI YuDong
    Jul 13, 2023

    HR Positive/HER2 Low Expression Metastatic Breast Cancer Trial in Guangzhou, Shantou, Qionghai (Disitamab vedotin, Endocrine

    Recruiting
    • HR Positive/HER2 Low Expression Metastatic Breast Cancer
    • Disitamab vedotin
    • Endocrine therapy
    • Guangzhou, Guangdong, China
    • +2 more
    Jun 19, 2023

    Breast Cancer Trial in Nanjing (Inetetamab, Pyrotinib, Oral Vinorelbine Tartrate)

    Recruiting
    • Breast Cancer
    • Nanjing, Jiangsu, China
      The First Affiliated Hospital with Nanjing Medical University
    Apr 10, 2023

    Breast Cancer Trial in Cambridge (Megestrol Acetate 40 MG, Megestrol Acetate 160 MG, Letrozole)

    Unknown status
    • Breast Cancer
    • Megestrol Acetate 40 MG
    • +2 more
    • Cambridge, Cambridgeshire, United Kingdom
      Cambridge University Hospitals NHS Foundation Trust
    Jan 12, 2021

    HER-2 Positive Breast Cancer Trial in Tianjin (TCbHP VS ddEC-THP)

    Recruiting
    • HER-2 Positive Breast Cancer
    • TCbHP VS ddEC-THP
    • Tianjin, Tianjin, China
      Breast Oncology, Tianjin Medical University Cancer Institute and
    May 15, 2023

    Breast Cancer Trial in Chengdu (Dalpiciclib combined with Letrozole)

    Not yet recruiting
    • Breast Cancer
    • Dalpiciclib combined with Letrozole
    • Chengdu, Sichuan, China
      West China Hospital, Sichuan University
    Aug 3, 2023

    HER2-positive Breast Cancer, ER-Negative Breast Cancer, PR-Negative Breast Cancer Trial in Belgium, France (Pertuzumab and

    Recruiting
    • HER2-positive Breast Cancer
    • +3 more
    • Pertuzumab and tratuzumab fixed dose combination
    • Trastuzumab emtansine
    • Auchenflower, Australia
    • +84 more
    Jan 16, 2023